We have a lot to share this Spring: a new webinar is coming up this month on the 25th, there is news about a recent FDA decision, we have added a Resources section to our website, and will be at PEGs Boston in May. We're looking forward to meeting and working with you!
In December 2022, the U.S. House of Representatives gave the final sign-off on the FDA Modernization Act 2.0, changing the face of drug development forever - read what TransCure CEO Patrick Nef thinks about this decision.
We have a new section of our website, Resources, where you can find summaries and links to latest publications that were either co-authored by us or include research utilizing our models and services.
The PEGS “Protein Engineering & Cell Therapy Summit” Boston Summit is an annual conference focused on protein and antibody engineering, held in Boston, Massachusetts. Dr. Kiave-Yune Ho Wang Yin, PhD, Director of Innovation and Business Development will be attending on our behalf from May 15th to 19th.
Follow us and share this newsletter on LinkedIn and Twitter
TransCure bioServices, Biopark, Le Forum 1, 260, av. Marie Curie, Archamps, France 74160, +33 4 57 62 83 79
